These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 3015772)
1. Factors affecting seropositivity to human T cell lymphotropic virus type III (HTLV-III) or lymphadenopathy associated virus (LAV) and progression of disease in sexual partners of patients with AIDS. Weber JN; McCreaner A; Berrie E; Wadsworth J; Jeffries DJ; Pinching AJ; Harris JR Genitourin Med; 1986 Jun; 62(3):177-80. PubMed ID: 3015772 [TBL] [Abstract][Full Text] [Related]
2. Introduction of lymphadenopathy associated virus or human T lymphotropic virus (LAV/HTLV-III) into the male homosexual community in Amsterdam. Coutinho RA; Krone WJ; Smit L; Albrecht-van Lent P; van der Noordaa J; Schaesberg W; Goudsmit J Genitourin Med; 1986 Feb; 62(1):38-43. PubMed ID: 3005159 [TBL] [Abstract][Full Text] [Related]
3. Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men. Jaffe HW; Feorino PM; Darrow WW; O'Malley PM; Getchell JP; Warfield DT; Jones BM; Echenberg DF; Francis DP; Curran JW Ann Intern Med; 1985 May; 102(5):627-8. PubMed ID: 2984973 [TBL] [Abstract][Full Text] [Related]
4. Relationship between antibody to LAV/HTLV-III and the natural course of subclinical cellular immune dysfunction in homosexual men. Collier AC; Meyers JD; Murphy VL; Roberts PL; Getchell JP; Handsfield HH Sex Transm Dis; 1987; 14(1):1-8. PubMed ID: 3645805 [TBL] [Abstract][Full Text] [Related]
6. Exposure to human T-lymphotropic virus type III/lymphadenopathy-associated virus and immunologic abnormalities in asymptomatic homosexual men. Nicholson JK; McDougal JS; Jaffe HW; Spira TJ; Kennedy MS; Jones BM; Darrow WW; Morgan M; Hubbard M Ann Intern Med; 1985 Jul; 103(1):37-42. PubMed ID: 2988389 [TBL] [Abstract][Full Text] [Related]
7. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822 [TBL] [Abstract][Full Text] [Related]
8. The Vancouver Lymphadenopathy-AIDS Study: 4. Effects of exposure factors, cofactors and HTLV-III seropositivity on number of helper T cells. Schechter MT; Boyko WJ; Jeffries E; Willoughby B; Nitz R; Constance P; Weaver M; Wiggs B; O'Shaughnessy M Can Med Assoc J; 1985 Aug; 133(4):286-92. PubMed ID: 2990652 [TBL] [Abstract][Full Text] [Related]
9. Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in Boston. Groopman JE; Mayer KH; Sarngadharan MG; Ayotte D; Devico AL; Finberg R; Sliski AH; Allan JD; Gallo RC Ann Intern Med; 1985 Mar; 102(3):334-7. PubMed ID: 2982305 [TBL] [Abstract][Full Text] [Related]
10. Sexual lifestyle and clinical findings related to HTLV-III/LAV status in homosexual men. Evans BA; Dawson SG; McLean KA; Teece SA; Key PR; Bond RA; Macrae KD; Jesson WJ; Mortimer PP Genitourin Med; 1986 Dec; 62(6):384-9. PubMed ID: 3469139 [TBL] [Abstract][Full Text] [Related]
11. Transmission of lymphadenopathy-associated virus/human T lymphotropic virus type III in sexual partners. Seropositivity does not predict infectivity in all cases. Burger H; Weiser B; Robinson WS; Lifson J; Engleman E; Rouzioux C; Brun-Vézinet F; Barré-Sinoussi F; Montagnier L; Chermann JC Am J Med; 1986 Jul; 81(1):5-10. PubMed ID: 3014878 [TBL] [Abstract][Full Text] [Related]
12. Association of human T lymphotropic virus type III antibodies with sexual and other behaviors in a cohort of homosexual men from Boston with and without generalized lymphadenopathy. Mayer KH; Ayotte D; Groopman JE; Stoddard AM; Sarngadharan M; Gallo R Am J Med; 1986 Mar; 80(3):357-63. PubMed ID: 3006486 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain. Cheingsong-Popov R; Weiss RA; Dalgleish A; Tedder RS; Shanson DC; Jeffries DJ; Ferns RB; Briggs EM; Weller IV; Mitton S Lancet; 1984 Sep; 2(8401):477-80. PubMed ID: 6147546 [TBL] [Abstract][Full Text] [Related]
14. The Vancouver Lymphadenopathy-AIDS Study: 2. Seroepidemiology of HTLV-III antibody. Jeffries E; Willoughby B; Boyko WJ; Schechter MT; Wiggs B; Fay S; O'Shaughnessy M Can Med Assoc J; 1985 Jun; 132(12):1373-7. PubMed ID: 2988729 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of antibody to LAV/HTLV-III among homosexual men in Seattle. Collier AC; Barnes RC; Handsfield HH Am J Public Health; 1986 May; 76(5):564-5. PubMed ID: 3008580 [TBL] [Abstract][Full Text] [Related]
16. HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia. Jason JM; McDougal JS; Dixon G; Lawrence DN; Kennedy MS; Hilgartner M; Aledort L; Evatt BL JAMA; 1986 Jan; 255(2):212-5. PubMed ID: 3001375 [TBL] [Abstract][Full Text] [Related]
17. Clinical findings and serological evidence of HTLV-III infection in homosexual contacts of patients with AIDS and persistent generalised lymphadenopathy in London. Gazzard BG; Shanson DC; Farthing C; Lawrence AG; Tedder RS; Cheingsong-Popov R; Dalgleish A; Weiss RA Lancet; 1984 Sep; 2(8401):480-3. PubMed ID: 6147547 [TBL] [Abstract][Full Text] [Related]
18. Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome. Kaplan JE; Oleske JM; Getchell JP; Kalyanaraman VS; Minnefor AB; Zabala-Ablan M; Joshi V; Denny T; Cabradilla CD; Rogers MF Pediatr Infect Dis; 1985; 4(5):468-71. PubMed ID: 2995933 [TBL] [Abstract][Full Text] [Related]
19. Three-year prospective study of HTLV-III/LAV infection in homosexual men. Weber JN; Wadsworth J; Rogers LA; Moshtael O; Scott K; McManus T; Berrie E; Jeffries DJ; Harris JR; Pinching AJ Lancet; 1986 May; 1(8491):1179-82. PubMed ID: 2871421 [TBL] [Abstract][Full Text] [Related]
20. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome. Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]